Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Randomized, Double-blind, Parallel-group, Clinical Study of S-649266 Compared With Meropenem for the Treatment of Hospital-acquired Bacterial Pneumonia, Ventilator-associated Bacterial Pneumonia, or Healthcare-associated Bacterial Pneumonia Caused by Gram-negative Pathogens

NCT03032380 is registered in ClinicalTrials.gov with Shionogi as lead sponsor.

NCT NCT03032380
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03032380 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Randomized, Double-blind, Parallel-group, Clinical Study of S-649266 Compared With Meropenem for the Treatment of Hospital-acquired Bacterial Pneumonia, Ventilator-associated Bacterial Pneumonia, or Healthcare-associated Bacterial Pneumonia Caused by Gram-negative Pathogens
Lead sponsor
Shionogi
Phase
Phase 3
Overall status
Completed
Start date
October 24, 2017
Completion date
April 1, 2019
Enrollment
300 (actual)
Sites
119

Conditions

As the registry lists them; a condition with its own page is linked.

healthcare-associated pneumonia (hcap), hospital acquired pneumonia (hap), ventilator associated pneumonia (vap)